II. Novel deaminated sulfadiazine metabolites in neonatal calf tissue, plasma, and urine following oral treatment of 14C-sulfadiazine.
D000818:Animals; D002417:Cattle; D055598:Chemical Phenomena; D002621:Chemistry; D004338:Drug Combinations / Q000008:administration & dosage; D008401:Gas Chromatography-Mass Spectrometry; D007668:Kidney / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009132:Muscles / Q000378:metabolism*; D013411:Sulfadiazine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism* / Q000652:urine; D014295:Trimethoprim / Q000008:administration & dosage; D000096926:Benzenesulfonamides
D004338:Drug Combinations; D013411:Sulfadiazine; D014295:Trimethoprim; C028512:2-benzenesulfonamido-4-hydroxypyrimidine; D000096926:Benzenesulfonamides; C024873:sulfadiazine, trimethoprim drug combination; C028511:2-benzenesulfonamidopyrimidine